1. Home
  2. GHRS vs GLDD Comparison

GHRS vs GLDD Comparison

Compare GHRS & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • GLDD
  • Stock Information
  • Founded
  • GHRS 2018
  • GLDD 1890
  • Country
  • GHRS Ireland
  • GLDD United States
  • Employees
  • GHRS N/A
  • GLDD N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • GLDD Military/Government/Technical
  • Sector
  • GHRS Health Care
  • GLDD Industrials
  • Exchange
  • GHRS Nasdaq
  • GLDD Nasdaq
  • Market Cap
  • GHRS 774.1M
  • GLDD 801.0M
  • IPO Year
  • GHRS 2021
  • GLDD 2006
  • Fundamental
  • Price
  • GHRS $13.10
  • GLDD $11.96
  • Analyst Decision
  • GHRS Strong Buy
  • GLDD
  • Analyst Count
  • GHRS 8
  • GLDD 0
  • Target Price
  • GHRS $30.63
  • GLDD N/A
  • AVG Volume (30 Days)
  • GHRS 307.7K
  • GLDD 443.1K
  • Earning Date
  • GHRS 11-13-2025
  • GLDD 11-04-2025
  • Dividend Yield
  • GHRS N/A
  • GLDD N/A
  • EPS Growth
  • GHRS N/A
  • GLDD 63.54
  • EPS
  • GHRS N/A
  • GLDD 1.06
  • Revenue
  • GHRS N/A
  • GLDD $830,567,000.00
  • Revenue This Year
  • GHRS N/A
  • GLDD $13.73
  • Revenue Next Year
  • GHRS N/A
  • GLDD $3.56
  • P/E Ratio
  • GHRS N/A
  • GLDD $11.29
  • Revenue Growth
  • GHRS N/A
  • GLDD 24.40
  • 52 Week Low
  • GHRS $6.00
  • GLDD $7.51
  • 52 Week High
  • GHRS $20.50
  • GLDD $12.89
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 45.98
  • GLDD 51.91
  • Support Level
  • GHRS $13.00
  • GLDD $11.82
  • Resistance Level
  • GHRS $14.96
  • GLDD $12.20
  • Average True Range (ATR)
  • GHRS 0.78
  • GLDD 0.30
  • MACD
  • GHRS -0.00
  • GLDD -0.04
  • Stochastic Oscillator
  • GHRS 28.46
  • GLDD 32.58

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: